← SynDRA
PALOMID-529
SynDRA canonical compound SYN0033801 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | MTOR |
| Mechanism of action | Fibroblast growth factor inhibitor |
All known targets
- MTOR
- FGF2
- MAPKAP1
- MTOR-RPTORA-MLST8-KT1S1-DEPTOR
Mechanisms of action (all sources)
- AKT1 INHIBITOR
- MTOR inhibitor
- VEGFR inhibitor
- Fibroblast growth factor inhibitor
- Serine/threonine-protein kinase mTOR inhibitor
- Inhibitor
- MAPKAP1 INHIBITOR
Cross-references
Synonyms
- P-529
- P529
- SG-00529
- Palomid 529
- P-529 (inhaled), Paloma
- P-529 (ophthalmic), Paloma
- P-529 (oral), Paloma
- P-529 (topical), Paloma
- P-529 drug eluting stent (cardiovascular disease), Paloma
- Palomid-529 (inhaled), Paloma
- Palomid-529 (ophthalmic), Paloma
- Palomid-529 (oral), Paloma
- Palomid-529 (topical), Paloma
- Palomid-529 drug eluting stent (cardiovascular disease), Paloma
- P-529 (intravitreal/subconjunctival), Paloma
- Palomid-529 (intravitreal/subconjunctival), Paloma
- Palomid 529 (P529)
- 8-(1-Hydroxyethyl)-2-methoxy-3-((4-methoxybenzyl)oxy)-6H-benzo[c]chromen-6-one
- 8-(1-hydroxyethyl)-2-methoxy-3-[(4-methoxyphenyl)methoxy]benzo[c]chromen-6-one
- UNII-XV9409EWG4
- 6H-Dibenzo(b,d)pyran-6-one, 8-(1-hydroxyethyl)-2-methoxy-3-((4-methoxyphenyl)methoxy)-
- 8-(1-hydroxyethyl)-2-methoxy-3-(4-methoxybenzyloxy)-6H-benzo[c]chromen-6-one
- Palomid529
- 6H-Dibenzo[b,d]pyran-6-one, 8-(1-hydroxyethyl)-2-methoxy-3-[(4-methoxyphenyl)methoxy]-
- 8-(1-Hydroxyethyl)-2-methoxy-3-[(4-methoxybenzyl)oxy]-6H-benzo[c]chromen-6-one
- RES-529
- XV9409EWG4
- Palomid 529,P529
- cc-513
- MLS006011187
- Palomid 529 - P529
- SCHEMBL290034
- C22H26Cl2N2O8
- CHEMBL2141712
- EX-A254
- QCR-215
- SYN5215
- BCPP000131
- HMS3655L14
Look up PALOMID-529 in the interactive SynDRA portal →